TITLE

Dances with the pharmaceutical industry

AUTHOR(S)
Gibson, Elaine; Baylis, Fran├žoise; Lewis, Steven
PUB. DATE
February 2002
SOURCE
CMAJ: Canadian Medical Association Journal;2/19/2002, Vol. 166 Issue 4, p448
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the case of Nancy Olivieri, a specialist in hereditary blood diseases at the Hospital for Sick Children (HSC) in Toronto, Ontario. Contracts of Olivieri with Apotex Inc. to test deferiprone on patients; Medical risks discovered by Olivieri; Studies of the legal and ethical aspects of Olivieri's relationships between Apotex and the HSC; Outlook for further studies.
ACCESSION #
6173547

 

Related Articles

  • Questions of interest.  // CMAJ: Canadian Medical Association Journal;2/19/2002, Vol. 166 Issue 4, p413 

    Editorial. Argues that an investigation into a case involving Nancy Olivieri, Apotex, the Hospital for Sick Children (HSC) and the University of Toronto should have been conducted by an impartial party. Public perception of Olivieri, due to the media; Issue of ethical research.

  • Canadian whistleblower row prompts broader code of conduct. Spurgeon, David // Nature;12/24/1998-12/31/1998, Vol. 396 Issue 6713, p715 

    Explains that the Medical Research Council of Canada (MRC) will broaden the ethical code of conduct for research involving humans. Decision due to a conflict between researcher Nancy Olivieri and Toronto's Hospital for Sick Children; Coverage by the current MRC code of conduct; Olivieri's...

  • Independent review adds to controversy at Sick Kids. Shuchman, Miriam // CMAJ: Canadian Medical Association Journal;2/09/99, Vol. 160 Issue 3, p386 

    Reports on the continuing controversy surrounding Dr. Nancy Olivieri of Toronto's Hospital for Sick Children (HSC). Olivieri's involvement in clinical trials for a drug called deferiprone; Concerns she had regarding side effects of the drug; Her failure to accurately report those concerns;...

  • Constraints of interest: lessons at the Hospital for Sick Children. Phillips, Robert A.; Hoey, John // CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p955 

    Editorial. Looks at the issues surrounding a dispute between Apotex Research Inc. and two physicians at the Hospital for Sick Children, Toronto, Canada over a clinical investigation. Relationship between the commercial and academic sectors in medicine; The contract that Drs. Gideon Koren and...

  • The Olivieri dispute: No end in sight? Shuchman, Miriam // CMAJ: Canadian Medical Association Journal;2/19/2002, Vol. 166 Issue 4, p487 

    Focuses on a dispute between Canadian Doctor Nancy Olivieri and the drug company Apotex about her research into the hazardous effects of deferiprone. Medical and professional ethics questions raised by the dispute; Results of studies of this dispute by various parties, including the Canadian...

  • The deferiprone furor. Parker, Shafer // Report / Newsmagazine (Alberta Edition);01/24/2000, Vol. 26 Issue 46, p14 

    Discusses a dispute between research physician Nancy Olivieri, formerly of Toronto, Ontario's Hospital for Sick Children, and Canadian company, Apotex Pharmaceuticals Inc. Her study for Apotex on the effectiveness of deferiprone, which is used in the treatment of thalassemia; Her conclusion...

  • Pregnant women wanted for morning sickness study.  // Nutrition Health Review: The Consumer's Medical Journal;1996, Issue 76, p16 

    Focuses on the Motherisk Program of the Hospital for Sick Children of Toronto's international study of the health problems caused by nausea and vomiting in pregnancy. Aim at determining the consequences of nausea to the health of mother and child; Contact information.

  • Cancer Treatment During Pregnancy: There's Strength in Numbers for Researchers. Beidler, Nora // JNCI: Journal of the National Cancer Institute;03/01/2000, Vol. 92 Issue 5, p372 

    Reports on the international registry of cases of cancer in pregnancy initiated by the Motherisk program at the Hospital for Sick Children in Toronto, Ontario. How the program works for both physicians and patients; Comments from Michael Lishner, co-director of Motherisk's Consortium of Cancer...

  • Manage myelomeningocele patients aggressively.  // Urology Times;Feb96, Vol. 24 Issue 2, p22 

    Reports on the treatment of myelomeningocele patients at the Hospital for Sick Children in Toronto, Ontario. Need for aggressive management of vesicoureteral reflux; Treatment used in resolving reflux; Protection of patients' upper tract.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics